Speedway Scene
Markets S&P 500 7,537.43 ▲ 0.72% Nasdaq 26,121.16 ▲ 1.12% Dow Jones 53,055.91 ▲ 0.29% US 10 Yr 4.48 ▼ 0.13% Crude Oil 68.73 ▲ 0.26% Gold 4,142.30 ▼ 0.60% Bitcoin 63,796 ▼ 0.31% FTSE 100 10,651.77 ▼ 0.26% EUR/USD 1.1448 ▲ 0.01% Nikkei 225 68,909.08 ▼ 1.19%
Topic

DNA Vaccine

Speedway Scene reporting, analysis and commentary on DNA Vaccine, pulled together from across our coverage.

1 article Last updated: 6 Jul 2026 1 section
Connected sections Health
Connected topics Tuberculosis Johns Hopkins Drug-Resistant TB Federal Reserve Donald Trump Ukraine
Lead story
Illustration of a nasally delivered DNA vaccine targeting tuberculosis bacteria in the lungs. Photo: SciTechDaily
Health

Nasal DNA Vaccine From Johns Hopkins Aims at the Tuberculosis Survivors Antibiotics Miss

A therapeutic intranasal DNA vaccine developed at Johns Hopkins fuses two genes to hunt the drug-tolerant TB bacteria that survive antibiotics and drive relapse, clearing infections faster in animal studies.

6 Jul 2026 ·6 min read
Read on

Keep following this story

Everything Speedway Scene has published on DNA Vaccine, gathered in one place: the reporting, the analysis and the commentary that track the subject.

Connected topics

Tuberculosis Johns Hopkins Drug-Resistant TB Federal Reserve Donald Trump Ukraine Iran World Cup 2026 Nasdaq NATO

Connected sections

Health

Nearby coverage

Health · 6 Jul 2026 Vera's Atacicept Meets the FDA Clock as IgA Nephropathy Waits on a First-in-Class Verdict Health · 6 Jul 2026 CDC Sees No Unusual H5N1 Signal at Home as Bird-Flu Deaths Climb Abroad Health · 6 Jul 2026 CDC Tally Puts 2026 Measles Within Reach of a Post-1991 Record Health · 6 Jul 2026 Medicare Opens the Door to Weight-Loss Drugs at $50 a Month, and to a Fight Over the Bill